@lengcute040: 😚

leen<33
leen<33
Open In TikTok:
Region: PH
Thursday 11 November 2021 14:28:19 GMT
821
201
2
0

Music

Download

Comments

dannieltzy1
Dᵃⁿⁿⁱᵉˡ🤫 :
weннн вaĸa rυpoĸ lodѕ ѕυre na yan вaĸa pagnaĸaнarap мarυpoĸ na😂😂😂
2021-11-14 09:04:58
1
ivanchua127
ivanchua127 :
notice lods pang myday lang 😅
2021-11-11 14:31:03
0
To see more videos from user @lengcute040, please go to the Tikwm homepage.

Other Videos

EpiPen Injection Slow Motion #curious The EpiPen, a life-saving auto-injector for treating severe allergic reactions, is significantly more expensive in the U.S. compared to countries with socialized healthcare systems. This price disparity is driven by several key factors: 1. Lack of Price Regulation in the U.S.: In the United States, drug prices are largely determined by pharmaceutical companies and the market, with minimal government regulation. Unlike countries with socialized healthcare systems, where governments negotiate or set drug prices, the U.S. does not have centralized bargaining power to keep costs down. This allows companies to set higher prices, especially for life-saving medications like the EpiPen. 2. Patent and Market Exclusivity: EpiPen’s manufacturer, Mylan (now Viatris), has maintained a strong market presence through patent protections and aggressive tactics to limit competition. Though other companies have tried to produce generic versions, the lack of competition has allowed the company to keep prices high in the U.S. In countries with socialized healthcare, governments often support the introduction of generics to increase competition and reduce prices. 3. Insurance and High Out-of-Pocket Costs: In the U.S., even though many people have health insurance, the cost of an EpiPen can still be prohibitively high due to high co-pays or deductibles. Without universal healthcare, individuals often bear more of the cost burden directly. In countries with socialized healthcare, patients typically receive medications at little or no cost because the government covers the majority of the expense through taxes. #allergy #health #money
EpiPen Injection Slow Motion #curious The EpiPen, a life-saving auto-injector for treating severe allergic reactions, is significantly more expensive in the U.S. compared to countries with socialized healthcare systems. This price disparity is driven by several key factors: 1. Lack of Price Regulation in the U.S.: In the United States, drug prices are largely determined by pharmaceutical companies and the market, with minimal government regulation. Unlike countries with socialized healthcare systems, where governments negotiate or set drug prices, the U.S. does not have centralized bargaining power to keep costs down. This allows companies to set higher prices, especially for life-saving medications like the EpiPen. 2. Patent and Market Exclusivity: EpiPen’s manufacturer, Mylan (now Viatris), has maintained a strong market presence through patent protections and aggressive tactics to limit competition. Though other companies have tried to produce generic versions, the lack of competition has allowed the company to keep prices high in the U.S. In countries with socialized healthcare, governments often support the introduction of generics to increase competition and reduce prices. 3. Insurance and High Out-of-Pocket Costs: In the U.S., even though many people have health insurance, the cost of an EpiPen can still be prohibitively high due to high co-pays or deductibles. Without universal healthcare, individuals often bear more of the cost burden directly. In countries with socialized healthcare, patients typically receive medications at little or no cost because the government covers the majority of the expense through taxes. #allergy #health #money

About